[ASAP] Response to “Selective PKCd Inhibitor B106 Elicits Uveal Melanoma Growth Inhibitory Effects Independent of Activated PKC Isoforms”

December 21st, 2018 by Douglas V. Faller

ACS Chemical Biology
DOI: 10.1021/acschembio.8b00959
  • Posted in ACS Chemical Biology, Publications
  • Comments Off on [ASAP] Response to “Selective PKCd Inhibitor B106 Elicits Uveal Melanoma Growth Inhibitory Effects Independent of Activated PKC Isoforms”